Fluorescent probes play a key role in modern biomedical research. As compared to inorganic quantum dots (QDs) composed with heavy metal elements, organic dye-based fluorescent nanoparticles have higher biocompatibility and are richer in variety. However, traditional organic fluorophores tend to quench fluorescence upon aggregation, which is known as aggregationcaused quenching (ACQ) effect that hinders the fabrication of highly emissive fluorescent nanoparticles. In this work, we demonstrate the synthesis of organic fluorescent dots with aggregation-induced emission (AIE) in far-red/near-infrared (FA/NIR) region. A conventional ACQ-characteristic fluorescent dye, 3,4:9,10-tetracarboxylic perylene bisimide (PBI), is converted into an AIE fluorogen through attaching two tetraphenylethylene (TPE) moieties. The fluorescent dots with surface folic acid groups are fabricated from PBI derivative (DTPEPBI), showing specific targeting effect to folate receptor-overexpressed cancer cells. In vivo studies also suggest that the folic acid-functionalized AIE dots preferentially accumulate in the tumor site through enhanced permeability and retention (EPR) effect and folate receptor-mediated active targeting effect. The low cytotoxicity, good FR/NIR contrast and excellent targeting ability in in vitro/in vivo imaging indicate that the AIE dots have great potentials in advanced bioimaging applications.
Introduction
In modern bioimaging applications, fluorescent techniques have been proven to be powerful tools in both fundamental research and practical applications [1] . Fluorescent probes play the essential role in bioimaging tasks to ensure desired fluorescence output with high sensitivity, motivating researchers to make great efforts to explore new generations of probes with high brightness, good photostability and feasible synthetic methods. Among various fluorescent probes, inorganic quantum dots (QDs) have shown great advantages in terms of better photostability and large Stokes shifts as compared to small organic dye molecules [2] . However, the intrinsic components of hazardous heavy metal elements may cause potential toxic issue [3] , which needs to be fully understood before using such QD probes for in vivo imaging studies. Moreover, the fluorescence of QDs tends to be diminished in acidic environment [4] , compromising the reliability during data analysis. As compared to inorganic QDs, various organic dye-loaded fluorescent nanoparticles have shown superior cytocompatibility and fluorescence stability to the QDs. However, conventional organic dyes always suffer weakened or annihilated fluorescence upon aggregation, which is known as aggregation-caused quenching (ACQ) [5] . Hence, the booming development in biomedical applications requires novel class of fluorescent probes with the hope to overcome the shortcomings of the inorganic QD probes and organic dye-loaded fluorescent nanoparticles.
Recently, we have reported several fluorogens that exhibited unique aggregation-induced emission (AIE) characteristics, which are directly opposite to ACQ and will greatly benefit the formulation of highly fluorescent nanoparticles [6, 7] . The AIE fluorogens are non-emissive when they are well-dissolved in solution but become highly emissive upon aggregation due to the restriction of intramolecular rotations (RIR) that activates radiative decay channels [8] . We found that simply attaching an iconic AIE unit, tetraphenylethene (TPE), to various conventional ACQ chromophores will facilitate the conversion to AIE ones, which offers a feasible and efficient approach to synthesize AIE fluorogens [9] . Additionally, using biocompatible distearoyl-sn-glycero-3-phosphoethanolamine-poly(ethylene glycol) (DSPE-PEG) derivatives as the encapsulation matrix, we have demonstrated that the AIE dots greatly outperform inorganic QD probes in in vitro and in vivo long-term cell tracing applications [10] . These results strongly suggest that the AIE fluorogens are promising candidates in the development of next generation of organic fluorescent dots.
In this contribution, we report the fabrication of AIE dots with far-red/near-infrared (FR/NIR) emission and demonstrate their performance in targeted imaging ability using a folate receptor-overexpressed tumor-baring mouse model. Through attaching TPE to a perylene-3,4:9,10-tetracarboxylic bisimide (PBI) derivative with typical ACQ effect, the obtained fluorogen shows pronounced AIE feature with efficient FR/NIR emission upon aggregation. Using the mixture of DSPE-PEG and DSPE-PEG-Folate as the encapsulation matrix, the obtained folate-functionalized AIE dots show higher targeting ability to folate receptor-overexpressed cancer cells and tumors as compared to AIE dots using DSPE-PEG alone during dot fabrication. This study opens a new window to synthesize fluorescent dots with FR/NIR emission and good biocompatibility to benefit the development of advanced imaging probes.
Experimental

Materials
[N,N′-dicyclohexyl-1,7-bis(4′-(1′,2′,2′-triphenyl)vinyl)phenylperylene-3,4:9,10-tetracarboxylic bisimide] (DTPEPBI) was synthesized according to literature [11] 
Synthesis of DTPEPBI based fluorescent dots
A THF solution (0.5 mL) containing 1 mg of DTPEPBI and 2 mg of mixture of DSPE-PEG 2000 and DSPE-PEG 5000 -Folate (molar percentage ratio of DSPE-PEG 5000 -Folate was 0% and 50%, respectively) was poured into 10 mL of 90% (v/v) water/THF solution. This was followed by sonication for 60 seconds at 12 W output using a microtip probe sonicator (XL2000, Misonix Incorporated, NY). The emulsion was then stirred at room temperature overnight to evaporate THF. AIE dots and Folate-AIE dots are assigned to DTPEPBI based fluorescent dots prepared without and with DSPE-PEG 5000 -Folate, respectively. The obtained solution was filtered using a 0.22 μm syringe-driven filter to collect the products.
Characterization methods
The UV-Vis spectra of dot suspensions in water were recorded on a Shimadzu UV-1700 spectrometer. The fluorescence spectra were measured using a fluorometer (LS-55, Perkin Elmer, USA). Average particle size and size distribution of the dots were determined by laser light scattering (LLS) with particle size analyzer (90 Plus, Brookhaven Instruments Co. USA) at a fixed angle of 90° at room temperature. The morphology of dots was also studied by highresolution transmission electron microscope (HR-TEM, JEM-2010F, JEOL, Japan).
Cell culture
Cells were cultured in folate-free Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum and 1% penicillin streptomycin at 37 °C in a humidified environment containing 5% CO 2 . Before experiment, the cells were pre-cultured until confluence was reached.
In vitro fluorescence imaging
MCF-7 breast cancer cells were cultured in the confocal imaging chambers (LAB-TEK, Chambered Coverglass System) at 37 °C. After 80% confluence, the medium was removed and the adherent cells were washed twice with 1× PBS buffer. The AIE dots and Folate-AIE dots in FBS-free DMEM medium at 2 M of DTPEPBI were then added to the chambers, respectively. After incubation for 2 h, the cells were washed three times with 1× PBS buffer and then fixed by 75% ethanol for 20 minutes, which were further washed twice with 1× PBS buffer and stained by DAPI for 10 min. The cell monolayer was then washed twice with 1× PBS buffer and imaged by confocal laser scanning microscope (CLSM, Zeiss LSM 410, Jena, Germany) with imaging software (Olympus Fluoview FV1000) under the same experimental condition. The fluorescence signal from dots was collected at 543 nm excitation with a 560 nm longpass barrier filter. For flow cytometry analysis, two groups of cells were trypsinized and fixed in 75% ethanol after incubation with AIE-dots and Folate-AIE dots, respectively. The cells were then suspended in 1 × PBS buffer and the fluorescence intensities were analyzed using Cyan-LX (DakoCytomation). The histogram of each sample was obtained by counting 10,000 events ( ex = 488 nm, 750 nm longpass filter).
Cytotoxicity studies
The cytotoxicity of AIE dots and Folate-AIE dots was evaluated using MCF-7 cells through MTT assay. In brief, MCF-7 cells were seeded in 96-well plates (Costar, IL, USA) at a density of 2 × 10 4 cells/mL. After 48 h incubation, the medium was discarded and AIE dots and Folate-AIE dots in DMEM with various concentrations were added into each sample wells for further incubation at 37 °C, respectively. To eliminate the UV absorption interference of DTPEPBI at 570 nm, the cells incubated with a series of AIE dots at the same doses but not post-treated by MTT were used as the control. After the designated time intervals, the sample wells were washed twice with 1× PBS buffer and 100 L of freshly prepared MTT (0.5 mg/mL) solution in culture medium was added into each well. After 3 h incubation in the incubator, the MTT medium solution was carefully removed, followed by addition of 100 L of DMSO into each well and the plate was gently shaken for 10 min at room temperature to dissolve all the precipitates formed. The absorbance of MTT at 570 nm was monitored by the microplate reader (Genios Tecan). Cell viability was expressed by the ratio of the absorbance of the cells incubated with fluorescent dot suspension to that of the cells incubated with culture medium only.
In vivo fluorescence imaging
All animal studies were performed in compliance with guidelines set by the Animal Care Committee at DrumTower Hospital. 0.1 mL of H 22 cell suspension containing 5 × 10 6 -6 × 10 6 cells were injected subcutaneously to ICR mice (average body weight of 25 g) at the left axilla. When the tumor volume reached a mean size of about 300 mm 3 , the mice were intravenously injected with 250 L of AIE dots and Folate-AIE dots, respectively, at the dye concentration of 4 mg/kg animal. Subsequently, the mice were anesthetized and placed on an animal plate heated to 37 °C. The biodistribution in mice was imaged using the Maestro in vivo fluorescence imaging system (CRi, Inc.). The light with a central wavelength at 523 nm was selected as the excitation source. In vivo spectral imaging from 560 to 900 nm (10 nm step) was conducted with an exposure time of 150 ms for each image frame. Auto-fluorescence was removed by using the spectral unmixing software. Scans were carried out at 2, 8 and 24 h post-injection.
Results and discussion
The fluorescent dots with aggregation-induced emission feature were synthesized through a nanoprecipitation method [12] . Using a mixture of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG 2000 ) and DSPE-PEG 5000 -Folate as the encapsulation matrix, the fluorescent dots with good biocompatibility and surface folic acid groups for folatereceptor overexpressed cancer cell targeting were obtained. Folate-AIE dots and AIE dots represent fluorescent dots that were formulated with encapsulation matrix containing 50% and 0% of DSPE-PEG 5000 -Folate, respectively. During formation, the hydrophobic DSPE segments tend to be embedded into the hydrophobic core with DTPEPBI while the hydrophilic PEG-folate chains extend into the aqueous phase.
Laser light scattering (LLS) result suggests that the volume average hydrodynamic diameter of Folate-AIE dots is 52 ± 3 nm (Figure 1(a) ), which is similar to that of the AIE dots (49 ± 2 nm). The morphology of Folate-AIE dots were studied by high-resolution transmission electron microscopy (HR-TEM), which is shown as the inset in Figures 1(a) . The black dots suggest that the spherical Folate-AIE dots can be clearly distinguished due to the high electron density of DTPEPBI molecules. Figure 1(b) shows the UV-Vis absorption and photoluminescence (PL) spectra of Folate-AIE dots in water, suggesting that the Folate-AIE dots have an emission maximum at 734 nm, which is similar to that of AIE dots in water (732 nm). The quantum yield of Folate-AIE dots in water is measured to be 3%, using rhodamine 6G in ethanol as the standard. The intense emission of Folate-AIE dots in FR/NIR window will greatly benefit in vivo experiments with deep tissue penetration depth and minimized autofluorescence interference.
MCF-7 breast cancer cells that are known to have high folate receptor expression level in cell membrane were chosen to evaluate the targeting ability of Folate-AIE dots over AIE dots without surface folic acid groups [13] . The effect of surface folic acid groups on internalization efficiency of the dots by MCF-7 breast cancer cells was investigated using confocal laser scanning microscopy. Figures 2(a) and (b) show the confocal images of MCF-7 breast cancer cells after incubation with AIE dots and Folate-AIE dots in freshly prepared culture medium for 2 h at DTPEPBI concentration of 2 M, respectively. The cell nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI). These images were taken upon excitation at 543 nm with a 560 nm longpass barrier filter. It should be noted that no auto fluorescence from the cell itself can be detected under the same experimental condition (Figure 2(c) ). Comparison between Figures 2(a) and (b) suggests that the fluorescence intensity from cell cytoplasm after incubation with Folate-AIE dots is higher than that after incubation with AIE dots. The higher fluorescence intensity of MCF-7 cancer cells in Figure 2 (a) as compared to that in Figure 3(b) suggests that more fluorescent dots are internalized into the cells due to specific interactions between folic acid on Folate-AIE dot surface and folate receptors in the cancer cell membrane, which should favor folate receptor-mediated endocytosis [14, 15] . The flow cytometry histograms of MCF-7 cancer cells after incubation with AIE dots and Folate-AIE dots are shown in Figure 2(d) , indicating that the average fluorescence intensity of each cell incubated with Folate-AIE dots is ~1.3 times higher as compared to that upon incubation with AIE dots. In addition, the cytotoxicity of both AIE dots and Folate-AIE dots was evaluated through methylthiazolyldiphenyltetrazolium bromide (MTT) assays. The results suggest that the metabolic viability of MCF-7 cancer cells after incubation with fluorescent dots at 2, 4 and 8 μM of DTPEPBI for 48 h remains above 90%, suggesting both AIE dots and Folate-AIE dots are of low cytotoxicity (Figure 2(e) ).
The performance of Folate-AIE dots in in vivo imaging was further investigated on a folate receptor-overexpressed tumor-bearing mouse model, using AIE dots without folic acids as the control. The animal model was established through subcutaneous inoculation of murine hepatic H 22 cancer cells into the right flank of each mouse. When the tumor volume reached about 300 mm 3 , the mice were in- travenously injected with AIE dots and Folate-AIE dots through tail vain, respectively. After designated time intervals upon injection, the mice were imaged by a Maestro EX in vivo fluorescence imaging system with a central wavelength at 523 nm as the excitation source. Figure 3(a) shows the in vivo distribution of AIE dots without folic acids in the tumor-bearing mouse at 2, 8 and 24 h post-injection. The FL intensities are indicated with different colors, and the order of red, orange, yellow, green, and blue refers to a successive decrease in intensity. Obvious fluorescence signal is observed in the area of tumor tissue at all the time points, suggesting that AIE dots have efficiently accumulated in tumor through enhanced permeability and retention (EPR) effect [16] . In addition, strong fluorescence from the liver region is also observed, which implicates that a portion of fluorescent dots in the blood circulation tend to be enriched in the liver, due to reticuloendothelial system (RES) uptake [17] . On the other hand, the specific tumor targeting ability of Folate-AIE dots is also evaluated on the same tumor-bearing mouse model (Figure 3(b) ). Much higher fluorescence intensity is shown in the tumor tissue of Folate-AIE dot-treated mouse as compared to that of AIE dot-treated mouse at all the time points, demonstrating the specific targeting ability of Folate-AIE dots to the tumor that contains folate receptor-overexpressed cancer cells in a living body. Noteworthy is that the ratio between fluorescence intensity from the tumor tissue and that from the liver tissue upon administration of Folate-AIE dots is significantly enhanced as compared to that upon administration of AIE dots. These results clearly indicate that Folate-AIE dots can be used as an effective fluorescent probe for in vivo tumor diagnosis with high specificity and good fluorescence contrast.
Conclusion
In this work, we successfully synthesized FR/NIR organic fluorescent dots using luminogens with aggregation-induced emission (AIE) feature as the core and biocompatible DSPE-PEG derivatives as the encapsulation matrix. Through mixing DSPE-PEG-Folate with DSPE-PEG, Folate-AIE dots with surface folic acid groups were obtained to facilitate targeted imaging studies. In vitro studies using MCF-7 cancer cells with high folate receptor overexpression as a model suggest that the folic acid-functionalized organic dots have higher living cell internalization efficiency as compared to AIE dots without surface folic acids, due to folate-receptor mediated endocytosis. The targeting ability of Folate-AIE dots to folate receptor-overexpressed tumor was also investigated on an animal model, indicating that Folate-AIE dots preferentially accumulated at the tumor site and the emission profile of the dots in FR/NIR region is greatly beneficial to in vivo fluorescence imaging. These results demonstrate the great potential of DTPEPBI-based Folate-AIE dots in cancer diagnosis with high specificity and good fluorescence contrast for in vivo studies. In future, such AIE dots with incorporation of therapeutic reagents will provide a promising platform to construct multifunctional dots for tumor diagnosis and treatment.
